StonvexLoading…
StonvexStonvexStonvexCore line items from BABA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-03-31 | Annual 2024 2024-03-31 | Annual 2023 2023-03-31 | Annual 2022 2022-03-31 |
|---|---|---|---|---|
Revenue | $137.30B | $130.35B | $126.49B | $134.57B |
Operating Income | $19.42B | $15.70B | $14.61B | $10.98B |
Net Income | $17.93B | $11.08B | $10.60B | $9.82B |
EPS (Diluted) | $0.92 | $0.54 | $0.50 | $0.45 |
Total Assets | $248.63B | $244.43B | $255.26B | $267.47B |
Total Liabilities | $98.41B | $90.33B | $91.75B | $96.75B |
Cash & Equivalents | $20.05B | $34.37B | $28.11B | $29.96B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 18.47B | 19.47B | 20.53B | 21.36B |